Regulation of Ras-Dependent Signal Transduction Pathways
Regulation of Ras-Dependent Signal Transduction Pathways
批准号:
7338463
负责人:
DEBORAH K MORRISON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Raf-1 kinase is an important signaling molecule, functioning in the Ras pathway to transmit mitogenic, differentiative, and oncogenic signals to the downstream kinases MEK and ERK. Due to its integral role in cell signaling, Raf-1 activity must be precisely controlled. During this past fiscal year, our reseach identified critical feedback phosphorylation sites that contribute to the downregulation of Raf-1 following mitogen stimulation. This work elucidated a key mechanism contributing to the temporal regulation of Ras/Raf signaling signaling and identified critical molecules involved in this process - ERK, PP2A and Pin1. KSR is a conserved component of the Ras pathway that acts as a molecular scaffold to facilitate signal transmission through the ERK cascade. During the past fiscal year, our studies provided novel insight into the endogenous scaffolding role of KSR1 within the nervous system. This work demonstrated that KSR1 functions biochemically in the hippocampus to scaffold the components of the ERK cascade, specifically regulating the cascade when a membrane fraction of ERK is activated via a PKC-dependent pathway but not via a cAMP/PKA-dependent pathway. Consistent with these findings, mice lacking KSR1 were found to have deficits in associative learning and certain typses of synaptic plasticity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INTERACTIONS OF PP60 C-SRC WITH POLYOMA MIDDLE T ANTIGEN
-
批准号:3033022
-
项目类别:
-
资助金额:$0.7万
-
财政年份:1988
-
负责人:DEBORAH K MORRISON
-
依托单位:
INTERACTIONS OF PP60 C-SRC WITH POLYOMA MIDDLE T ANTIGEN
-
批准号:3033021
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1987
-
负责人:DEBORAH K MORRISON
-
依托单位:
REGULATION OF RAS DEPENDENT SIGNAL TRANSDUCTION PATHWAYS
-
批准号:6419915
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DEBORAH K MORRISON
-
依托单位:
Regulation of Ras-Dependent Signal Transduction Pathways
-
批准号:6951343
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DEBORAH K MORRISON
-
依托单位:
Regulation of Ras-Dependent Signal Transduction Pathways
-
批准号:6763545
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DEBORAH K MORRISON
-
依托单位:
Regulation of Ras-Dependent Signal Transduction Pathways
-
批准号:7291711
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DEBORAH K MORRISON
-
依托单位:
Regulation of Ras Dependent Signal Transduction Pathways
-
批准号:6559212
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DEBORAH K MORRISON
-
依托单位:
Regulation of Ras-Dependent Signal Transduction Pathways
-
批准号:7052419
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DEBORAH K MORRISON
-
依托单位:
Regulation of Ras-Dependent Signal Transduction Pathways
-
批准号:7733001
-
项目类别:
-
资助金额:$51.95万
-
财政年份:--
-
负责人:DEBORAH K MORRISON
-
依托单位:
Regulation of Ras-Dependent Signal Transduction Pathways
-
批准号:7592665
-
项目类别:
-
资助金额:$123.7万
-
财政年份:--
-
负责人:DEBORAH K MORRISON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
-
批准号:2026JJ81256
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李弘德
-
依托单位:
槲皮素基于P53/Ras调控细胞凋亡增殖抗OSF癌变的机制研究
-
批准号:2026JJ82512
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王韧
-
依托单位:
lncRNA H19通过介导Ras/ULK1信号影响乳腺癌细胞线粒体稳态及糖酵解的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:施文标
-
依托单位:
组织驻留菌Eggerthella lenta 通过代
谢重编程Ras通路介导的细胞凋亡抑制结
直肠癌的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:陈一纬
-
依托单位:
新型污染物三(2-氯丙基)磷酸酯通过RAS/NLRP3信号通路致肾纤维化机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李升
-
依托单位:
赛沃替尼+西妥昔单抗+FOLFOX化疗对比西妥昔单抗+FOLFOX化疗一线治疗RAS/BRAF野生型转移性结直肠癌:一项前瞻性随机、对照、多中心、开放性研究
-
批准号:25SF1901600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:许剑民
-
依托单位:
氨基酸突变Ras构象和作用机理的深入分
析导向肿瘤药物发现
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:曾娟
-
依托单位:
生育三烯酚调节RAS-ERK-MAPK通路促糖尿病溃疡愈合的机制研究
-
批准号:2025JJ80977
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:兰宏伟
-
依托单位:
全基因组CRISPR-Cas9筛选RAS/MAPK信号通路失活诱导非小细胞肺癌第三代EGFR-TKI耐药机制研究
-
批准号:JCZRLH202500317
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
牙周膜应力介导RAS信号通路调控破骨细胞增殖和分化促进牙周辅助加速正畸的机制研究
-
批准号:2025JJ70585
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:黄勉芳
-
依托单位: